Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec 1;27(12):1257-1260.
doi: 10.5551/jat.ED135. Epub 2020 Jun 24.

Loss of Skeletal Muscle Mass and Poor Prognosis in Patients with ST-Segment Elevation Myocardial Infarction: Underling Mechanisms and Therapeutic Strategies

Kazunori Shimada  1   2
Affiliations
Editorial

Loss of Skeletal Muscle Mass and Poor Prognosis in Patients with ST-Segment Elevation Myocardial Infarction: Underling Mechanisms and Therapeutic Strategies

Kazunori Shimada. J Atheroscler Thromb. .
No abstract available

Keywords: Myocardial infarction; Physical activity; Prognosis; Sarcopenia; Skeletal muscle mass.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1.
Fig. 1.
Protein synthesis and degradation of skeletal muscle AR, adrenergic receptor; IGF, insulin-like growth factor; IGF1R, IGF-1 receptor; PI3K, phosphoinositide 3-kinase; mTOR, mammalian target of rapamycin; p70S6K, p70 ribosomal S6 kinase; ActRIIB, activin receptor IIb; AKT, serine/threonine-protein kinase; FOXO, Forkhead box O protein (FOXO); atrogin-1, MAFbx/atrogin-1; MuRF-1, muscle RING finger-1; RAS, renin-angiotensin system; AT1R, angiotensin II type 1 receptor.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Mauriac C.: Essai sur les maladies de coeur: de la mort subite dans l'insuffisance das valvules sigmoides de l'aorte, L. 1860; Leclerc, Paris
    1. Rosenberg IH: Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr, 1989; 50: 1231-1233
    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People. Sarcopenia : European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 2010; 39: 412-423 - PMC - PubMed
    1. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H: Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc, 2014; 15: 95-101 - PubMed
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 : Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019; 48: 16-31 - PMC - PubMed

Publication types